Entity > Corporation > US > New York City New York > Exelixis
About Exelixis
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Exelixis
| Company Attribute | Value |
| Name | Exelixis |
| Url | exelixis |
| Wikidata | wikidata |
Exelixis
New York City, US
18 May 2024
Exelixis
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.exelixis.com/
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the ...
Rich Sitelinks
People Also Ask
https://www.linkedin.com/company/exelixis
We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
https://en.wikipedia.org › wiki › Exelixis
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. ...
https://finance.yahoo.com › quote › EXEL
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the ...
https://twitter.com/exelixisinc?lang=en
We take pride in our ongoing efforts to foster a diverse and inclusive scientific community where everyone can explore a career in STEM.
https://finance.yahoo.com › quote › EXEL › profile
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United ...
https://ipira.berkeley.edu › exelixis-inc
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery ...
Related Searches
exelixis layoffs
exelixis products
exelixis meaning
Knowledge Panel
Exelixis (Biotech company)
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
-
Stock price : EXEL (NASDAQ) $20.91 -0.32 (-1.51%)May 17, 4:00 PM EDT - Disclaimer
-
Headquarters : Alameda, CA
-
CEO : Michael M. Morrissey (Jul 2010–)
-
Subsidiaries : Exelixis Patent Company LLC, Exelixis U.S., LLC, MORE
-
President : Michael M. Morrissey
-
Founders : Corey S. Goodman, Stelios Papadopoulos
-
Revenue : 1.435 billion USD (2021)
-
Founded : November 15, 1994, Cambridge, MA